Circular rna vaccines against sars-cov-2 variants and methods of use thereof
AssigneePeking University
InventorsWensheng WEI, Liang QU, Zongyi YI, Yong SHEN, Liangru LIN, Feng CHEN
Life of this patent
Estimating the term…
Loading patent…
AssigneePeking University
InventorsWensheng WEI, Liang QU, Zongyi YI, Yong SHEN, Liangru LIN, Feng CHEN
Estimating the term…
Provided are circular RNAs (circRNAs) encoding an antigenic polypeptide of a SARS-CoV-2 variant. Provided are circRNA vaccines against a SARS-CoV-2 variant, such as a Delta or Omicron variant. The circRNA vaccine comprises a circRNA comprising a nucleic acid sequence encoding an antigenic polypeptide comprising a Spike(S) protein or a fragment thereof of a SRAS-CoV-2 variant. Also provided are methods of treating or preventing a SARS-CoV-2 infection using the circRNAs or compositions thereof.
A circular RNA (circRNA) comprising a nucleic acid sequence encoding an antigenic polypeptide of a SARS-CoV-2 variant, wherein the SARS-CoV-2 variant is a Delta variant or an Omicron variant.
-14. (canceled)
(canceled)
(canceled)
-25. (canceled)
(canceled)
-31. (canceled)
Dependencies are inferred from the claim text.